Utilization of personalized tumor-specific methylation haplotypes of circulating DNA to monitor minimal residual disease in patients with hepatocellular carcinoma undergoing curative resection

被引：0
|
作者：
Yang, Xin-Rong
Guo, De-Zhen
Zhang, Shi-Yu
Xu, Min-Jie
Chen, Hua
Ma, Cheng-Cheng
Fu, Rui-Qing
Su, Ming-Yang
He, Qi-Ye
Zhang, Yun-Zhi
Su, Zhi-Xi
Liu, Rui
Fan, Jia
Zhou, Jian
机构：
[1] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai, Peoples R China
[3] Singlera Genom Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16245
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
    Chen, Huijuan
    Zhou, Qiming
    ONCOLOGY REPORTS, 2023, 49 (05)
  • [32] HBV VIRUS-HOST CHIMERA DNA SERVES AS A PERSONALIZED CIRCULATING BIOMARKER FOR RESIDUAL TUMORS AFTER SURGICAL RESECTION OF HEPATOCELLULAR CARCINOMA
    Chau, Gar-Yang
    Lee, Wei-Chen
    Ho, Ming-Chih
    Chen, Teng-Wei
    Hu, Rey-Heng
    Wu, Tsung-Han
    Lei, Hao-Jan
    Chou, Shu-Cheng
    Fan, Hsiu-Lung
    Wu, Ting-Jung
    Ho, Cheng-Maw
    Chou, Hong-Shiue
    Tzeng, Sheng-Tai
    Wang, Ya-Chun
    Yeh, Shiou-Hwei
    Chen, Pei-Jer
    HEPATOLOGY, 2023, 78 : S198 - S198
  • [33] Circulating Tumor DNA in Patients Undergoing Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases
    Hong, Hanna
    Wehrle, Chase J.
    Fares, Sami
    Stitzel, Henry
    Estfan, Bassam
    Kamath, Suneel
    Krishnamurthi, Smitha
    Ma, Wen Wee
    Khalil, Mazhar
    Pita, Alejandro
    Schlegel, Andrea
    Kim, Jaekeun
    Hashimoto, Koji
    Walsh, R. Matthew
    Kwon, David C. H.
    Aucejo, Federico
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S185 - S186
  • [34] WHOLE-GENOME SEQUENCING YIELDS TUMOR-SPECIFIC DNA REARRANGEMENTS AS TARGETS FOR MINIMAL RESIDUAL DISEASE DETECTION IN NEUROBLASTOMA
    van Wezel, Esther M.
    Zappeij-Kannegieter, Lily
    Zwijnenburg, Danny A.
    Koster, Jan
    Molenaar, Jan J.
    Versteeg, Rogier
    Caron, Huib N.
    van der Schoot, C. Ellen
    Tytgat, Godelieve A.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1013 - 1013
  • [35] Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach
    Honore, N.
    Galot, R.
    van Marcke, C.
    Helaers, R.
    Mendola, A.
    Limaye, N.
    Machiels, J-P.
    ORAL ONCOLOGY, 2021, 118
  • [36] Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
    Liu, Tao
    Yao, Qianqian
    Jin, Hai
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy
    Lutfi, Areeb
    Afghan, Maaz K.
    Kasi, Pashtoon M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [38] Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Cirmena, Gabriella
    Garuti, Anna
    De Mariano, Marilena
    Coco, Simona
    Ferrando, Lorenzo
    Isnaldi, Edoardo
    Barbero, Valentina
    Fregatti, Piero
    Del Mastro, Lucia
    Ferrando, Fabio
    Gonella, Roberta
    Garlaschi, Alessandro
    Friedman, Daniele
    Ballestrero, Alberto
    Zoppoli, Gabriele
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [39] Circulating tumor DNA and urine tumor DNA detection of minimal residual disease in upper tract urothelial carcinoma with radical nephroureterectomy: A cohort study
    Xue, W.
    Cui, X.
    Pan, X.
    Hao, Q.
    Guo, L.
    Pang, F.
    Huang, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1221 - S1221
  • [40] Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.
    Guo, De-Zhen
    Zhang, Shi-Yu
    Gu, Zhu-Jun
    Zhou, Shuang-Tao
    Jin, Da-Wei
    Yang, Shuang
    Fan, Jia
    Zhou, Jian
    Yang, Xin-Rong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345